Skip to main content
Premium Trial:

Request an Annual Quote

Komen Foundation, American Airlines to Raise $8M for Breast Cancer 'Omics

NEW YORK (GenomeWeb News) – Susan G. Komen for the Cure, a non-profit breast cancer research advocacy organization, has teamed with American Airlines to raise $8 million to support a project at the University of Texas’ MD Anderson Cancer Center that will use genomics, proteomics, and nanotechnology to study and treat inflammatory breast cancer.
Under the terms of the agreement, American will raise $7.5 million for Komen's first Promise Grant, which will support the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic for eight years.
The focus of the research will be to discover ways to diagnose IBC earlier and to develop treatments tailored to the disease.
IBC is a rare but aggressive form of breast cancer that is not detectable by mammography or ultrasound, and which is “often resistant to existing breast cancer treatments,” Komen for the Cure said.
Komen said it started the Promise Grants program to get researchers to collaborate in new ways to develop breast cancer diagnostic tools and treatments.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.